世界の尋常性天疱瘡治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Pemphigus Vulgaris Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12562 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、尋常性天疱瘡治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。尋常性天疱瘡治療の種類別市場規模（経口、注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・尋常性天疱瘡治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Novartis、GlaxoSmithKline、Mylan、Genentech、Principia Biopharma、Argenx、Alexion、Vifor Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・尋常性天疱瘡治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・尋常性天疱瘡治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・尋常性天疱瘡治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・尋常性天疱瘡治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・尋常性天疱瘡治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Pemphigus Vulgaris Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pemphigus Vulgaris Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pemphigus Vulgaris Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Pemphigus Vulgaris Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Injectable

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
Roche
Novartis
GlaxoSmithKline
Mylan
Genentech
Principia Biopharma
Argenx
Alexion
Vifor Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Pemphigus Vulgaris Treatment
1.2 Classification of Pemphigus Vulgaris Treatment by Type
1.2.1 Overview: Global Pemphigus Vulgaris Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pemphigus Vulgaris Treatment Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Injectable
1.3 Global Pemphigus Vulgaris Treatment Market by Application
1.3.1 Overview: Global Pemphigus Vulgaris Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pemphigus Vulgaris Treatment Market Size & Forecast
1.5 Global Pemphigus Vulgaris Treatment Market Size and Forecast by Region
1.5.1 Global Pemphigus Vulgaris Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pemphigus Vulgaris Treatment Market Size by Region, (2016-2021)
1.5.3 North America Pemphigus Vulgaris Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Pemphigus Vulgaris Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pemphigus Vulgaris Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Pemphigus Vulgaris Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pemphigus Vulgaris Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pemphigus Vulgaris Treatment Market Drivers
1.6.2 Pemphigus Vulgaris Treatment Market Restraints
1.6.3 Pemphigus Vulgaris Treatment Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Pemphigus Vulgaris Treatment Product and Solutions
2.1.4 Roche Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Pemphigus Vulgaris Treatment Product and Solutions
2.2.4 Novartis Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Pemphigus Vulgaris Treatment Product and Solutions
2.3.4 GlaxoSmithKline Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Pemphigus Vulgaris Treatment Product and Solutions
2.4.4 Mylan Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mylan Recent Developments and Future Plans
2.5 Genentech
2.5.1 Genentech Details
2.5.2 Genentech Major Business
2.5.3 Genentech Pemphigus Vulgaris Treatment Product and Solutions
2.5.4 Genentech Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Genentech Recent Developments and Future Plans
2.6 Principia Biopharma
2.6.1 Principia Biopharma Details
2.6.2 Principia Biopharma Major Business
2.6.3 Principia Biopharma Pemphigus Vulgaris Treatment Product and Solutions
2.6.4 Principia Biopharma Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Principia Biopharma Recent Developments and Future Plans
2.7 Argenx
2.7.1 Argenx Details
2.7.2 Argenx Major Business
2.7.3 Argenx Pemphigus Vulgaris Treatment Product and Solutions
2.7.4 Argenx Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Argenx Recent Developments and Future Plans
2.8 Alexion
2.8.1 Alexion Details
2.8.2 Alexion Major Business
2.8.3 Alexion Pemphigus Vulgaris Treatment Product and Solutions
2.8.4 Alexion Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Alexion Recent Developments and Future Plans
2.9 Vifor Pharma
2.9.1 Vifor Pharma Details
2.9.2 Vifor Pharma Major Business
2.9.3 Vifor Pharma Pemphigus Vulgaris Treatment Product and Solutions
2.9.4 Vifor Pharma Pemphigus Vulgaris Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Vifor Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pemphigus Vulgaris Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pemphigus Vulgaris Treatment Players Market Share
3.2.2 Top 10 Pemphigus Vulgaris Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Pemphigus Vulgaris Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pemphigus Vulgaris Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Pemphigus Vulgaris Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pemphigus Vulgaris Treatment Revenue Market Share by Application (2016-2021)
5.2 Pemphigus Vulgaris Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pemphigus Vulgaris Treatment Revenue by Type (2016-2026)
6.2 North America Pemphigus Vulgaris Treatment Revenue by Application (2016-2026)
6.3 North America Pemphigus Vulgaris Treatment Market Size by Country
6.3.1 North America Pemphigus Vulgaris Treatment Revenue by Country (2016-2026)
6.3.2 United States Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pemphigus Vulgaris Treatment Revenue by Type (2016-2026)
7.2 Europe Pemphigus Vulgaris Treatment Revenue by Application (2016-2026)
7.3 Europe Pemphigus Vulgaris Treatment Market Size by Country
7.3.1 Europe Pemphigus Vulgaris Treatment Revenue by Country (2016-2026)
7.3.2 Germany Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
7.3.3 France Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Pemphigus Vulgaris Treatment Market Size by Region
8.3.1 Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Region (2016-2026)
8.3.2 China Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
8.3.5 India Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pemphigus Vulgaris Treatment Revenue by Type (2016-2026)
9.2 South America Pemphigus Vulgaris Treatment Revenue by Application (2016-2026)
9.3 South America Pemphigus Vulgaris Treatment Market Size by Country
9.3.1 South America Pemphigus Vulgaris Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Pemphigus Vulgaris Treatment Market Size by Country
10.3.1 Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Pemphigus Vulgaris Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Pemphigus Vulgaris Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pemphigus Vulgaris Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pemphigus Vulgaris Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pemphigus Vulgaris Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pemphigus Vulgaris Treatment Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Pemphigus Vulgaris Treatment Product and Solutions
Table 9. Roche Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Pemphigus Vulgaris Treatment Product and Solutions
Table 13. Novartis Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Pemphigus Vulgaris Treatment Product and Solutions
Table 17. GlaxoSmithKline Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mylan Corporate Information, Head Office, and Major Competitors
Table 19. Mylan Major Business
Table 20. Mylan Pemphigus Vulgaris Treatment Product and Solutions
Table 21. Mylan Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Genentech Corporate Information, Head Office, and Major Competitors
Table 23. Genentech Major Business
Table 24. Genentech Pemphigus Vulgaris Treatment Product and Solutions
Table 25. Genentech Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Principia Biopharma Corporate Information, Head Office, and Major Competitors
Table 27. Principia Biopharma Major Business
Table 28. Principia Biopharma Pemphigus Vulgaris Treatment Product and Solutions
Table 29. Principia Biopharma Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Argenx Corporate Information, Head Office, and Major Competitors
Table 31. Argenx Major Business
Table 32. Argenx Pemphigus Vulgaris Treatment Product and Solutions
Table 33. Argenx Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Alexion Corporate Information, Head Office, and Major Competitors
Table 35. Alexion Major Business
Table 36. Alexion Pemphigus Vulgaris Treatment Product and Solutions
Table 37. Alexion Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Vifor Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Vifor Pharma Major Business
Table 40. Vifor Pharma Pemphigus Vulgaris Treatment Product and Solutions
Table 41. Vifor Pharma Pemphigus Vulgaris Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Pemphigus Vulgaris Treatment Revenue (USD Million) by Players (2019-2021)
Table 43. Global Pemphigus Vulgaris Treatment Revenue Share by Players (2019-2021)
Table 44. Breakdown of Pemphigus Vulgaris Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Pemphigus Vulgaris Treatment Players Head Office, Products and Services Provided
Table 46. Pemphigus Vulgaris Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Pemphigus Vulgaris Treatment New Entrants and Expansion Plans
Table 48. Global Pemphigus Vulgaris Treatment Revenue (USD Million) by Type (2016-2021)
Table 49. Global Pemphigus Vulgaris Treatment Revenue Share by Type (2016-2021)
Table 50. Global Pemphigus Vulgaris Treatment Revenue Forecast by Type (2021-2026)
Table 51. Global Pemphigus Vulgaris Treatment Revenue by Application (2016-2021)
Table 52. Global Pemphigus Vulgaris Treatment Revenue Forecast by Application (2021-2026)
Table 53. North America Pemphigus Vulgaris Treatment Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Pemphigus Vulgaris Treatment Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Pemphigus Vulgaris Treatment Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Pemphigus Vulgaris Treatment Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Pemphigus Vulgaris Treatment Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Pemphigus Vulgaris Treatment Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Pemphigus Vulgaris Treatment Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Pemphigus Vulgaris Treatment Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Pemphigus Vulgaris Treatment Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Pemphigus Vulgaris Treatment Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Pemphigus Vulgaris Treatment Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Pemphigus Vulgaris Treatment Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Pemphigus Vulgaris Treatment Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Pemphigus Vulgaris Treatment Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Pemphigus Vulgaris Treatment Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Pemphigus Vulgaris Treatment Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Pemphigus Vulgaris Treatment Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Pemphigus Vulgaris Treatment Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Pemphigus Vulgaris Treatment Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Pemphigus Vulgaris Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pemphigus Vulgaris Treatment Picture
Figure 2. Global Pemphigus Vulgaris Treatment Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injectable
Figure 5. Pemphigus Vulgaris Treatment Revenue Market Share by Application in 2020
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Global Pemphigus Vulgaris Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Pemphigus Vulgaris Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Pemphigus Vulgaris Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Pemphigus Vulgaris Treatment Revenue Market Share by Region in 2020
Figure 13. North America Pemphigus Vulgaris Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Pemphigus Vulgaris Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Pemphigus Vulgaris Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Pemphigus Vulgaris Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Pemphigus Vulgaris Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Pemphigus Vulgaris Treatment Market Drivers
Figure 19. Pemphigus Vulgaris Treatment Market Restraints
Figure 20. Pemphigus Vulgaris Treatment Market Trends
Figure 21. Roche Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. GlaxoSmithKline Recent Developments and Future Plans
Figure 24. Mylan Recent Developments and Future Plans
Figure 25. Genentech Recent Developments and Future Plans
Figure 26. Principia Biopharma Recent Developments and Future Plans
Figure 27. Argenx Recent Developments and Future Plans
Figure 28. Alexion Recent Developments and Future Plans
Figure 29. Vifor Pharma Recent Developments and Future Plans
Figure 30. Global Pemphigus Vulgaris Treatment Revenue Share by Players in 2020
Figure 31. Pemphigus Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Pemphigus Vulgaris Treatment Revenue Market Share in 2020
Figure 33. Global Top 10 Players Pemphigus Vulgaris Treatment Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Pemphigus Vulgaris Treatment Revenue Share by Type in 2020
Figure 36. Global Pemphigus Vulgaris Treatment Market Share Forecast by Type (2021-2026)
Figure 37. Global Pemphigus Vulgaris Treatment Revenue Share by Application in 2020
Figure 38. Global Pemphigus Vulgaris Treatment Market Share Forecast by Application (2021-2026)
Figure 39. North America Pemphigus Vulgaris Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Pemphigus Vulgaris Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Pemphigus Vulgaris Treatment Revenue Market Share by Country (2016-2026)
Figure 42. United States Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Pemphigus Vulgaris Treatment Sales Market Share by Type (2016-2026)
Figure 46. Europe Pemphigus Vulgaris Treatment Sales Market Share by Application (2016-2026)
Figure 47. Europe Pemphigus Vulgaris Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Pemphigus Vulgaris Treatment Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Pemphigus Vulgaris Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Pemphigus Vulgaris Treatment Revenue Market Share by Region (2016-2026)
Figure 56. China Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Pemphigus Vulgaris Treatment Sales Market Share by Type (2016-2026)
Figure 63. South America Pemphigus Vulgaris Treatment Sales Market Share by Application (2016-2026)
Figure 64. South America Pemphigus Vulgaris Treatment Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Pemphigus Vulgaris Treatment Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Pemphigus Vulgaris Treatment Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Pemphigus Vulgaris Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Pemphigus Vulgaris Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source

---